09:56 AM EST - Numinus Wellness Inc. : Congratulates the Multidisciplinary Association of Psychedelics Studies on the results of their phase 3 results. These findings were published last week in the peer-reviewed medical journal, Nature Medicine. Numinus Wellness Inc.
shares T.NUMI are trading down $0.01 at $0.22.
